PH12019502335A1 - Thermo-responsive gelling artificial lacrima - Google Patents

Thermo-responsive gelling artificial lacrima

Info

Publication number
PH12019502335A1
PH12019502335A1 PH12019502335A PH12019502335A PH12019502335A1 PH 12019502335 A1 PH12019502335 A1 PH 12019502335A1 PH 12019502335 A PH12019502335 A PH 12019502335A PH 12019502335 A PH12019502335 A PH 12019502335A PH 12019502335 A1 PH12019502335 A1 PH 12019502335A1
Authority
PH
Philippines
Prior art keywords
thermo
composition
present
responsive gelling
artificial lacrima
Prior art date
Application number
PH12019502335A
Other languages
English (en)
Inventor
Takeshi Yamamura
Ayaka YAMAMURO
Emi IZUKURA
Moto KIMURA
Tomohiro Otsuka
Original Assignee
Wakamoto Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wakamoto Pharma Co Ltd filed Critical Wakamoto Pharma Co Ltd
Publication of PH12019502335A1 publication Critical patent/PH12019502335A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5383—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/717—Celluloses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
PH12019502335A 2017-04-25 2019-10-14 Thermo-responsive gelling artificial lacrima PH12019502335A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2017086512 2017-04-25
JP2017249891 2017-12-26
PCT/JP2018/016854 WO2018199180A1 (ja) 2017-04-25 2018-04-25 熱ゲル化人工涙液

Publications (1)

Publication Number Publication Date
PH12019502335A1 true PH12019502335A1 (en) 2020-09-14

Family

ID=63919901

Family Applications (1)

Application Number Title Priority Date Filing Date
PH12019502335A PH12019502335A1 (en) 2017-04-25 2019-10-14 Thermo-responsive gelling artificial lacrima

Country Status (16)

Country Link
US (2) US10532026B2 (cg-RX-API-DMAC10.html)
EP (1) EP3593806B1 (cg-RX-API-DMAC10.html)
JP (2) JP6473274B1 (cg-RX-API-DMAC10.html)
KR (2) KR102083253B1 (cg-RX-API-DMAC10.html)
CN (2) CN110913867B (cg-RX-API-DMAC10.html)
AU (1) AU2018257301B2 (cg-RX-API-DMAC10.html)
BR (1) BR112019018368B1 (cg-RX-API-DMAC10.html)
CA (1) CA3025567C (cg-RX-API-DMAC10.html)
ES (1) ES2912289T3 (cg-RX-API-DMAC10.html)
MX (2) MX379302B (cg-RX-API-DMAC10.html)
MY (2) MY196565A (cg-RX-API-DMAC10.html)
PH (1) PH12019502335A1 (cg-RX-API-DMAC10.html)
RU (1) RU2710366C1 (cg-RX-API-DMAC10.html)
SG (1) SG11201909170QA (cg-RX-API-DMAC10.html)
TW (1) TWI733019B (cg-RX-API-DMAC10.html)
WO (1) WO2018199180A1 (cg-RX-API-DMAC10.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11202007977RA (en) * 2018-02-28 2020-09-29 Santen Pharmaceutical Co Ltd Ophthalmic composition comprising diquafosol and cationic polymer
TW202000196A (zh) * 2018-03-01 2020-01-01 日商石原產業股份有限公司 保存安定性優異之醫藥組成物
WO2020175525A1 (ja) * 2019-02-27 2020-09-03 参天製薬株式会社 ジクアホソルまたはその塩、ビニル系高分子およびセルロース系高分子を含有する眼科用組成物

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2125060C (en) * 1993-07-02 1999-03-30 Henry P. Dabrowski Ophthalmic solution for artificial tears
JP3450805B2 (ja) * 2000-08-08 2003-09-29 わかもと製薬株式会社 水性医薬組成物
JP2003095924A (ja) * 2001-07-16 2003-04-03 Wakamoto Pharmaceut Co Ltd 熱ゲル化人工涙液
GB0210794D0 (en) * 2002-05-10 2002-06-19 Chart Heat Exchangers Ltd Heat exchangers
JP4263456B2 (ja) 2002-03-18 2009-05-13 わかもと製薬株式会社 ヒアルロン酸含有熱ゲル化製剤
JP4263418B2 (ja) * 2002-03-18 2009-05-13 わかもと製薬株式会社 熱ゲル化人工涙液
EP1681065A4 (en) 2003-10-31 2011-12-28 Wakamoto Pharma Co Ltd WATER-BASED COMPOSITION SUBJECTED TO REVERSIBLE THERMOREGULATION
JP5649261B2 (ja) * 2004-05-07 2015-01-07 ロート製薬株式会社 高粘度点眼剤
JP5661981B2 (ja) * 2004-11-26 2015-01-28 大正製薬株式会社 眼科用剤
CN101784287B (zh) * 2007-06-26 2013-04-24 若素制药株式会社 水性组合物

Also Published As

Publication number Publication date
MX2018014935A (es) 2019-04-09
KR102281853B1 (ko) 2021-07-23
WO2018199180A1 (ja) 2018-11-01
EP3593806A4 (en) 2020-03-25
CN113332233B (zh) 2022-02-25
EP3593806B1 (en) 2022-03-30
JPWO2018199180A1 (ja) 2019-06-27
MX379302B (es) 2025-03-11
BR112019018368A2 (pt) 2020-04-07
MY196323A (en) 2023-03-24
KR20190110624A (ko) 2019-09-30
TW201842900A (zh) 2018-12-16
ES2912289T3 (es) 2022-05-25
KR102083253B1 (ko) 2020-03-02
RU2710366C1 (ru) 2019-12-26
JP6473274B1 (ja) 2019-02-20
CN113332233A (zh) 2021-09-03
AU2018257301A1 (en) 2019-08-22
KR20200020999A (ko) 2020-02-26
JP6736705B2 (ja) 2020-08-05
BR112019018368B1 (pt) 2021-03-02
CN110913867B (zh) 2021-06-11
US20180360746A1 (en) 2018-12-20
MY196565A (en) 2023-04-19
JP2019104740A (ja) 2019-06-27
CA3025567C (en) 2019-10-22
US20200121592A1 (en) 2020-04-23
AU2018257301B2 (en) 2019-10-31
CN110913867A (zh) 2020-03-24
US11096889B2 (en) 2021-08-24
SG11201909170QA (en) 2019-11-28
TWI733019B (zh) 2021-07-11
CA3025567A1 (en) 2018-11-01
EP3593806A1 (en) 2020-01-15
US10532026B2 (en) 2020-01-14

Similar Documents

Publication Publication Date Title
MX2023003124A (es) Composiciones farmaceuticas oftalmicas y usos que se relacionan a las mismas.
MX2018010788A (es) Composicion oftalmologica.
WO2016178586A3 (en) Collagen compositions and preparation and uses thereof
EP2996172A3 (en) Biocompatibility of biomedical energization elements
PH12017501956A1 (en) Compositions of obeticholic acid and methods of use
WO2015120231A3 (en) Stable peptide formulations and methods for preparation
BR112015022161A2 (pt) implante intraocular contendo prostamida
PH12017502376B1 (en) Oral solid formulation containing irinotecan and method of preparing the same
WO2016140933A3 (en) Immediate release soluble ibuprofen compositions
GEP20237486B (en) Formulations of copanlisib
EP4364741A3 (en) Polymorphic form of tg02
MX2018014935A (es) Lagrima artificial de gelificacion termo-responsiva.
TR201713929A2 (tr) Ki̇tosan ve alji̇natin hemostati̇k kompozi̇syonlari
WO2015017340A3 (en) Low swell tissue adhesive and sealant formulations
TN2017000445A1 (en) Drippable ophthalmic bimatoprost gel
PH12016502386B1 (en) Oral care compositions
MX2019013942A (es) Una composición agroquímica estable y el proceso de esta.
WO2018085495A3 (en) Dissolvable films and methods of their use
WO2016197042A8 (en) Modified or targeted release formulations of linaclotide
ZA201906037B (en) Liquid composition containing pradofloxacin
MX377823B (es) Composición nasal con capacidades de formación de película.
WO2019125166A3 (en) Hyaluronic acid formulations
PH12016502527A1 (en) Stabilized desmopressin
NZ762357A (en) Composition for calcium supplementation
WO2019078791A3 (en) Shape memory tubular retractor and self-expanding graft- coated nitinol tubular retractor arrangement